Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Congress Spending More Time at Home: Good News for Advocates

  |  

Members of Congress will spend more time in their respective districts this year. This is great news for both experienced and new advocates, because members of Congress are often more accessible when they are home. If you are apprehensive about meeting with your members of Congress in Washington, D.C., these district work periods provide the perfect opportunity to begin building a valuable relationship with your legislators. Here are a few ways for you to reach out to your legislators while they are at home.

Are We There Yet?

David Borenstein, MD  |  

Advancing rheumatology through public relations

Promoting Arthritis Research to Congress and Others

  |  

The ACR works to promote clinical and basic research in arthritis and musculoskeletal disease through a variety of channels, including advocacy, working directly with the National Institutes of Health (NIH), and through the work of the ACR Research and Education Foundation.